Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010842 · ClinicalTrials.gov registry record · Phase 1
Natural Antioxidants in the Treatment of Multiple Sclerosis
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00010842 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH).
The verdict
NCT00010842, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to compare the effectiveness of three antioxidant regimens in treating the symptoms of multiple sclerosis (MS).
Interventions
- DRUG Ginkgo biloba
- DRUG Alpha-lipoic acid
- DRUG Vitamin E/Selenium
- DRUG Essential fatty acids
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-09 |
| Est. Completion | 2004-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00010842
The ClinicalTrials.gov registry entry for NCT00010842 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ginkgo biloba is the first listed.
NCT00010842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00010842 about?
NCT00010842 is a clinical study titled "Natural Antioxidants in the Treatment of Multiple Sclerosis". The purpose of this study is to compare the effectiveness of three antioxidant regimens in treating the symptoms of multiple sclerosis (MS).
What is the current status of trial NCT00010842?
This trial is currently completed. It is a Phase 1 study. The study started on 1999-09. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00010842?
The interventions under investigation include: Ginkgo biloba (DRUG), Alpha-lipoic acid (DRUG), Vitamin E/Selenium (DRUG), Essential fatty acids (DRUG).
Who is sponsoring clinical trial NCT00010842?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.